Carna Biosciences, Inc.

IR NewsInvestors

IR News 2017

Nov 21, 2017
NEWS
CB1763, a novel non-covalent BTK inhibitor, has advanced to preclinical development.
Nov 20, 2017
FINANCIALS
Aug 08, 2017
FINANCIALS
May 12, 2017
FINANCIALS
Feb 13, 2017
FINANCIALS